JLB, we have been on couple forums, namely BAL and MFG and I do enjoy your posts. However I do disagree with your interpretation about the guidance forecast for second half. Your interpreting the revenue going backwards but i see it going forward of up to 25%. My interpretation is Geoff was hosing down expectations due to supply constraints and volatile Chinese regulations. His done the right thing. Another few point of differences between A2 and BAL are:
1) A2 demand is higher than what BAL experienced
2) Singles day performance blitzed BAL, filling top few spots in Stage 3
3) Clearly has Diagou support
4) Better management
For the SP to go back below $1.80, revenue will need to drop substantially. I don't see it happening.
However the next 6 months is the key for A2. If you follow the timeline of BAL and BKL, it is around this time that revenue began to drop.
- Forums
- ASX - By Stock
- A2M
- Half yearly earnings.
Half yearly earnings., page-46
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.080(1.63%) |
Mkt cap ! $3.518B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $5.926M | 1.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3951 | $5.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.44 | 257 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 6230 | 4.810 |
24 | 57456 | 4.800 |
14 | 62021 | 4.790 |
12 | 140601 | 4.780 |
8 | 107984 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.820 | 20547 | 28 |
4.830 | 6676 | 10 |
4.840 | 77374 | 12 |
4.850 | 62021 | 9 |
4.860 | 1815 | 4 |
Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online